{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:49:50Z","timestamp":1789390190744,"version":"build-2803163510"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Global Infect Dis"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0974-777x.68537","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T07:56:09Z","timestamp":1283327769000},"page":"284","source":"Crossref","is-referenced-by-count":22,"title":["Cephalosporin resistance in Neisseria gonorrhoeae"],"prefix":"10.4103","volume":"2","author":[{"given":"Manju","family":"Bala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-777X.68537-1","unstructured":"WHO. Global prevalence and incidence of selected curable sexually transmitted infections: Overviews and estimates. WHO\/HIV_AIDS\/2001-02. Geneva: WHO; 2001."},{"key":"key-10.4103\/0974-777X.68537-2","first-page":"12","volume-title":"Global prevalence and incidence estimates of selected curable STDs","author":"Gerbase","year":"1998","journal-title":"Sex Transm Infect"},{"key":"key-10.4103\/0974-777X.68537-3","first-page":"1848","volume-title":"Reduction of concentration of HIV - 1 in semen after treatment of urethritis: implications for prevention of transmission of HIV- 1","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"key-10.4103\/0974-777X.68537-4","first-page":"85","volume-title":"The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosupression in female sex workers in Abidjan, Cote d\u2032Ivoire","author":"Ghys","year":"1997","journal-title":"AIDS"},{"key":"key-10.4103\/0974-777X.68537-5","first-page":"922","volume-title":"Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina","author":"Mostad","year":"1997","journal-title":"Lancet"},{"key":"key-10.4103\/0974-777X.68537-6","first-page":"167","volume-title":"Increase in endocervical CD4 lymphocytes among women with non-ulcerative sexually transmitted diseases","author":"Levine","year":"1998","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-7","unstructured":"Tapsall JW. Antimicrobial resistance in N. gonorrhoeae. WHO\/CDS\/DRS\/ 2001.3. Geneva: World Health Organization, 2001. Available from: http:\/\/www.who.int\/csr\/resources\/publications\/drugresist\/WHO_CDS_CSR_DRS_2001_3\/en\/. [cited on 2009 Jul 23]."},{"key":"key-10.4103\/0974-777X.68537-8","first-page":"775","volume-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: Data for the years 1994 - 2004","author":"Stathi","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68537-9","first-page":"1251","volume-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu Province, China, with a focus on fluoroquinolone resistance","author":"Wang","year":"2006","journal-title":"J Med Microbiol"},{"key":"key-10.4103\/0974-777X.68537-10","first-page":"318","volume-title":"Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidleberg areas of Southern Germany","author":"Enders","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-11","first-page":"523","volume-title":"Alarming increase in ciprofloxacin and penicillin resistant Neisseria gonorrhoeae isolates in New Delhi, India","author":"Bala","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-12","first-page":"582","volume-title":"Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N.gonorrhoeae strains","author":"Bala","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68537-13","first-page":"S263","volume-title":"Antibiotic resistance in Neisseria gonorrhoeae","author":"Tapsall","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-14","unstructured":"World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva, Switzerland: 2003."},{"key":"key-10.4103\/0974-777X.68537-15","first-page":"S84","volume-title":"Update on the management of gonorrhea in adults in the United States","author":"Newman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-16","first-page":"737","volume-title":"The treatment of syphilis and gonorrhea as of today","author":"Nelson","year":"1944","journal-title":"Am J Nurs"},{"key":"key-10.4103\/0974-777X.68537-17","first-page":"81","volume-title":"Introduction of sulfonamide therapy for gonorrhea","author":"Kampmeier","year":"1983","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-18","first-page":"656","volume-title":"\u03b2-lactamase-producing, penicillin resistant gonococcus","author":"Phillips","year":"1976","journal-title":"Lancet"},{"key":"key-10.4103\/0974-777X.68537-19","first-page":"191","volume-title":"Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980","author":"Jaffe","year":"1981","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-20","first-page":"607","volume-title":"A community-based outbreak of infection with penicillin resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance)","author":"Faruki","year":"1985","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-777X.68537-21","first-page":"1739","volume-title":"Treatment of uncomplicated infections due to Neisseria gonorrhoeae","author":"Rice","year":"1986","journal-title":"JAMA"},{"key":"key-10.4103\/0974-777X.68537-22","first-page":"56","volume-title":"Tetracycline in the treatment of uncomplicated male gonorrhoea","author":"Judson","year":"1976","journal-title":"Y Am Ven Dis Assn"},{"key":"key-10.4103\/0974-777X.68537-23","first-page":"351","volume-title":"Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae","author":"Katz","year":"1992","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-24","first-page":"819","volume-title":"Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated high-level resistance to tetracycline","author":"Knapp","year":"1987","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-25","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 1997. Division of STD Prevention, Centers for Disease Control and Prevention [CDC], September 1998."},{"key":"key-10.4103\/0974-777X.68537-26","first-page":"107","volume-title":"Antibiotic susceptibility of Neisseria gonorrhoeae in Trinidad and Tobago","author":"Swanston","year":"1997","journal-title":"West Indian Med J"},{"key":"key-10.4103\/0974-777X.68537-27","first-page":"210","volume-title":"Antimicrobial susceptibility and plasmid profile of Neisseria gonorrhoeae in India [New Delhi]","author":"Bhalla","year":"1998","journal-title":"Sex Transm Inf"},{"key":"key-10.4103\/0974-777X.68537-28","doi-asserted-by":"crossref","unstructured":"Knapp JS, Wongba C, Limpakarnjanarat K, Young NL, Parekh MC, Neal SW, et al. Antimicrobial susceptibility of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Sex Transm Dis 1997;24:142-8","DOI":"10.1097\/00007435-199703000-00004"},{"key":"key-10.4103\/0974-777X.68537-29","first-page":"105","volume-title":"Plasmid patterns and antimicrobial susceptibilities of Neisseria gonorrhoeae in Bandung, Indonesia","author":"Djajakusumah","year":"1998","journal-title":"Trans Royal Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.68537-30","first-page":"1","volume-title":"1993 sexually transmitted diseases treatment guidelines","author":"Centers","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"key-10.4103\/0974-777X.68537-31","first-page":"25","volume-title":"Ofloxacin, a new quinolone for the treatment of gonorrhoea","author":"Rajakumar","year":"1988","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-32","first-page":"81","volume-title":"Multicenter trial of fleroxacin vs ceftriaxone in the treatment of uncomplicated gonorrhoea","author":"Smith","year":"1993","journal-title":"Am J Med"},{"key":"key-10.4103\/0974-777X.68537-33","first-page":"39","volume-title":"Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important?","author":"Moran","year":"1995","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-34","first-page":"90","volume-title":"High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan","author":"Tanaka","year":"1994","journal-title":"Genitourin Med"},{"key":"key-10.4103\/0974-777X.68537-35","unstructured":"Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae-Colorado and Washington, 1995. MMWR Morb Mortal Wkly Rep 1995;44:761-4"},{"key":"key-10.4103\/0974-777X.68537-36","first-page":"425","volume-title":"Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995","author":"Tapsall","year":"1996","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-37","first-page":"1041","volume-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae-Hawaii and California, 2001","author":"Centers","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.4103\/0974-777X.68537-38","unstructured":"Moran JS, Handsfield HH. Neisseria gonorrhoeae. In: Yu VL, Weber R, Raoult D, editors. Antimicrobial therapy and vaccines. 2 nd ed. New York: Apple Trees Productions; 2002. p. 457-69."},{"key":"key-10.4103\/0974-777X.68537-39","unstructured":"BASHH (British Association for Sexual Health and HIV). National Guidelines on the Diagnosis and Treatment of Gonorrhoea in Adults 2005."},{"key":"key-10.4103\/0974-777X.68537-40","unstructured":"Treatment Guidelines of STD. In: Sharma VK, editor. Sexually Transmitted Diseases and AIDS. WHO\/CDC\/NACO, Appendix II. New Delhi: 2003. p. 489-98."},{"key":"key-10.4103\/0974-777X.68537-41","first-page":"256","volume-title":"Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci","author":"Tapsall","year":"2009","journal-title":"Sex Transm Inf"},{"key":"key-10.4103\/0974-777X.68537-42","first-page":"1417","volume-title":"Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhoea","author":"Judson","year":"1985","journal-title":"JAMA"},{"key":"key-10.4103\/0974-777X.68537-43","first-page":"919","volume-title":"Single-dose cefixime vs single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection","author":"Plourde","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-44","first-page":"386","volume-title":"Which cephalosporin for gonorrhoea?","author":"Ison","year":"2004","journal-title":"Sex Transm Infect"},{"key":"key-10.4103\/0974-777X.68537-45","first-page":"1764","volume-title":"Orally administered cefpodoxime proxetil for the treatment of uncomplicated gonococcal urethritis in males: a dose-response study","author":"Novak","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-46","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2006 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report - 2006. Atlanta, GA: US Department of Health and Human Services; 2008. Available from: http:\/\/www.cdc.gov\/STD\/gisp2006\/GISPSurvSupp2006Complete.pdf.\/. [cited on 2009 Jul 28]."},{"key":"key-10.4103\/0974-777X.68537-47","first-page":"3564","volume-title":"Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection","author":"Lo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-48","first-page":"555","volume-title":"The use of cephalosporins for gonorrhea: The impending problem of resistance","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0974-777X.68537-49","first-page":"272","volume-title":"Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae","author":"Boslego","year":"1987","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-777X.68537-50","first-page":"1","volume-title":"Sexually transmitted diseases treatment guidelines, 2006","author":"Centers","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.4103\/0974-777X.68537-51","doi-asserted-by":"crossref","unstructured":"Kojima M, Masuda K, Yada Y, Hayase Y, Muratani T, Matsumoto T. Single-dose treatment of male patients with gonococcal urethritis using 2 g spectinomycin: Microbiological and clinical evaluations. Int J Antimicrob Agents 2008;32:50-4.","DOI":"10.1016\/j.ijantimicag.2008.02.023"},{"key":"key-10.4103\/0974-777X.68537-52","first-page":"370","volume-title":"Notice to readers: Discontinuation of spectinomycin","author":"Centers","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.4103\/0974-777X.68537-53","unstructured":"Centers for Disease Control and Prevention (CDC). Gonococcal Isolate Surveillance Project (GISP) annual report-2004. Atlanta: CDC; 2005."},{"key":"key-10.4103\/0974-777X.68537-54","first-page":"186","volume-title":"First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India","author":"Bala","year":"2005","journal-title":"Sex Transm Inf"},{"key":"key-10.4103\/0974-777X.68537-55","first-page":"48","volume-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006","author":"WHO","year":"2008","journal-title":"Commun Dis Intell"},{"key":"key-10.4103\/0974-777X.68537-56","first-page":"115","volume-title":"Resistance of Neisseria gonorrhoeae epidemic strains to antibiotics: Report of resistant isolates and surveillance in Zhanjiang, China: 1998 to 1999","author":"Guoming","year":"2000","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-57","first-page":"921","volume-title":"A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis","author":"Martin","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-777X.68537-58","first-page":"545","volume-title":"Azithromycin for empirical treatment of the non-gonococcal urethritis syndrome in men: a randomized double-blind study","author":"Stamm","year":"1995","journal-title":"JAMA"},{"key":"key-10.4103\/0974-777X.68537-59","first-page":"107","volume-title":"Multicenter trial of single-dose azithromycin vs.ceftriaxone in the treatment of uncomplicated gonorrhoea","author":"Handsfield","year":"1994","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-60","first-page":"109","volume-title":"Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women","author":"Waugh","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68537-61","unstructured":"Centers for Disease Control and Prevention. Updated recommended treatment regimens for gonococcal infections and associated conditions - United States, April 2007. Available from: http:\/\/www.cdc.gov\/std\/treatment\/2006\/updated-regimens.htm. [cited on 2009 Jul 24]."},{"key":"key-10.4103\/0974-777X.68537-62","first-page":"299","volume-title":"Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin","author":"Young","year":"1997","journal-title":"Int J STD AIDS"},{"key":"key-10.4103\/0974-777X.68537-63","first-page":"505","volume-title":"Failure of azithromycin therapy in gonorrhoea and discorrelation with laboratory parameters","author":"Tapsall","year":"1998","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-64","first-page":"147","volume-title":"Current concepts in the management of gonorrhoea","author":"Tapsall","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0974-777X.68537-65","first-page":"84","volume-title":"Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea","author":"Waters","year":"2005","journal-title":"Int J STD AIDS"},{"key":"key-10.4103\/0974-777X.68537-66","first-page":"81","volume-title":"Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance","author":"Wang","year":"2007","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0974-777X.68537-67","unstructured":"Health Protection Agency. Health Protection Report 2008;2:No 14 (4 April)."},{"key":"key-10.4103\/0974-777X.68537-68","first-page":"490","volume-title":"Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland","author":"Palmer","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68537-69","first-page":"49","volume-title":"Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase","author":"Akasaka","year":"2001","journal-title":"J Infect Chemother"},{"key":"key-10.4103\/0974-777X.68537-70","first-page":"3603","volume-title":"Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan","author":"Muratani","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-71","first-page":"3185","volume-title":"Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","author":"Ito","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-72","first-page":"1275","volume-title":"Threat to cefixime treatment for gonorrhea","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-73","first-page":"849","volume-title":"Multi-drug resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001","author":"Wang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-74","first-page":"129","volume-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004","author":"WHO","year":"2006","journal-title":"Commun Dis Intell"},{"key":"key-10.4103\/0974-777X.68537-75","first-page":"3111","volume-title":"Diversity of penA alterations and subtypes of Neisseria gonorrhoeae less susceptible to ceftriaxone from Sydney, Australia","author":"Whiley","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-76","first-page":"941","volume-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2005 in Bangui, Central African Republic; Yaounde, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam","author":"Cao","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-77","first-page":"637","volume-title":"Cluster of multi drug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece","author":"Tzelepi","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68537-78","first-page":"3931","volume-title":"Molecular epidemiology of gonorrhea identified clonal clusters with distinct susceptibilities associated with specific high-risk groups","author":"Wong","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68537-79","first-page":"268","volume-title":"Multidrug-resistant Neisseria gonorrhoeae","author":"Tapsall","year":"2009","journal-title":"CMAJ"},{"key":"key-10.4103\/0974-777X.68537-80","doi-asserted-by":"crossref","unstructured":"Tapsall JW, Unemo M, Lewis D, Ndowa F. Meeting the public health challenge of multi- and extensively-drug resistant Neisseria gonorrhoeae. Expert Rev Anti-Infect Ther 2009 in press.","DOI":"10.1586\/eri.09.63"},{"key":"key-10.4103\/0974-777X.68537-81","first-page":"20","volume-title":"Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype","author":"Tanaka","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.68537-82","unstructured":"Takahashi K, Muratani T, Kobayashi T, Yamada Y, Inatomi H, Matsumoto T. Emergence and prevalence of multi-drug resistant Neisseria gonorrhoeae (fluoroquinolones, tetracyclines, penicillins, 1 st and 2 nd generation cephems, and oral 3 rd generation cephems) in Japan [abstract 882]. In: Program and abstracts of the 2001 Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago).Washington, DC: American Society for Microbiology, 2001."},{"key":"key-10.4103\/0974-777X.68537-83","first-page":"587","volume-title":"European Surveillance of Sexually Transmitted Infections (ESSTI): The first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe","author":"Martin","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68537-84","first-page":"137","volume-title":"Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan","author":"Ito","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-85","first-page":"561","volume-title":"DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae","author":"Deguchi","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-86","first-page":"1020","volume-title":"Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles","author":"Deguchi","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-87","first-page":"382","volume-title":"Prevention of drug access to bacterial targets: Permeability barriers and active efflux","author":"Nikaido","year":"1994","journal-title":"Science"},{"key":"key-10.4103\/0974-777X.68537-88","first-page":"414","volume-title":"Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae","author":"Johnson","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.68537-89","first-page":"2468","volume-title":"Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations","author":"Zarantonelli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-90","first-page":"1293","volume-title":"Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae","author":"Maness","year":"1974","journal-title":"J Bacteriol"},{"key":"key-10.4103\/0974-777X.68537-91","first-page":"913","volume-title":"Insertion of an extra amino acid is the main cause of the low affinity of penicillin-binding protein 2 in penicillin-resistant strains of Neisseria gonorrhoeae","author":"Brannigan","year":"1990","journal-title":"Mol Microbiol"},{"key":"key-10.4103\/0974-777X.68537-92","first-page":"2799","volume-title":"Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus","author":"Gill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-93","first-page":"611","volume-title":"Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system","author":"Hagman","year":"1995","journal-title":"Microbiology"},{"key":"key-10.4103\/0974-777X.68537-94","first-page":"769","volume-title":"Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae","author":"Ropp,","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-95","first-page":"374","volume-title":"Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime","author":"Ameyama","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-96","first-page":"173","volume-title":"Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae","author":"Spratt","year":"1988","journal-title":"Nature"},{"key":"key-10.4103\/0974-777X.68537-97","first-page":"2117","volume-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: Association with genetic polymorphisms in penA, mtrR, porB1b, and ponA","author":"Lindberg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68537-98","first-page":"86","volume-title":"Evaluation of activity of sixteen medicinal plants against Neisseria gonorrhoeae","author":"Shokeen","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.68537-99","first-page":"106","volume-title":"Preliminary Studies on Activity of Ocimum sanctum, Drynaria quercifolia and Annona squamosa against Neisseria gonorrhoeae","author":"Shokeen","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.4103\/0974-777X.68537-100","first-page":"271","volume-title":"In vitro anti-Neisseria gonorrhoeae activity of Terminalia macroptera leaves","author":"Silva","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"key-10.4103\/0974-777X.68537-101","first-page":"174","volume-title":"In-vitro activity of Eugenol, an active component from Ocimum sanctum against multiresistant and susceptible strains of Neisseria gonorrhoeae","author":"Shokeen","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.68537-102","first-page":"410","volume-title":"Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model","author":"Spencer","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.68537-103","first-page":"180","volume-title":"A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens","author":"Talwar","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.68537-104","first-page":"606","volume-title":"Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies","author":"Workowski","year":"2008","journal-title":"Ann Intern Med"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:55:53Z","timestamp":1786632953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-777X.68537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["68537"],"URL":"https:\/\/doi.org\/10.4103\/0974-777x.68537","relation":{},"ISSN":["0974-777X"],"issn-type":[{"value":"0974-777X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}